Fluxion Biosciences



View all Products

BioFlux 200
BioFlux provides a fully integrated solution for running biologically relevant cellular assays under shear flow. The system utiliz...

View Product

BioFlux 1000
BioFlux provides a fully integrated solution for running biologically relevant cellular assays under shear flow. The system utiliz...

View Product

IonFlux 16
The IonFlux 16 is the world's first multi-channel automated patch clamp instrument designed and priced for the research environment. The sy...

View Product

IonFlux HT
The IonFlux HT is the world's highest throughput and most economical automated patch clamp instrument designed. The system utilizes Fluxion...

View Product

Browse All Fluxion Biosciences Products (see all)

Browse Products by Field

Basic Research (4)

Drug Discovery & Development (1)

Life Sciences (4)

Pre-Clinical Development (2)

Target Discovery (4)




Company Profile


Quick Facts

  • Founded: 2005
  • Location: South San Francisco, California, USA (directions)
  • Principal focus: analytical instruments for functional cell-based assays
  • Products:
    - BioFlux system for live cell analysis under shear flow
    - IonFlux system for automated patch clamping

Customer Focused

Fluxion's goal is to create innovative solutions for its customers which offer superior performance, simplified workflows and cost savings over conventional assay techniques. Fluxion's customers include:

  • Biotech and pharmaceutical companies - Johnson & Johnson, Pfizer, Genentech
  • Leading academic institutions- Harvard, Stanford, Cornell
  • Government research organizations - NIH, Walter Reed, Lawrence Berkeley

Product Development Strategy

Fluxion works closely with its customers and collaborators to develop new products and applications. The company's first two products, BioFlux and IonFlux, were the result of extensive product development and testing both internally and with leading academic and biopharmaceutical institutions.

In 2008, BioFlux 200 was the recipient of the R&D 100 Award given by R&D Magazine to the top 100 new technologies of the year. In 2010, Fluxion received another R&D100 award for the IonFlux HT system.

Advanced Research and Development

In addition to its core product lines, Fluxion is also engaged in cutting-edge research to produce the next generation of breakthrough technologies. Fluxion has been awarded several research grants from the National Institutes of Health to develop platforms for critical disease research areas.

Leadership

Fluxion is led by an experienced team of professionals from the bioanalytical tool industry. The Board of Directors comprises senior executives and investors representing some of the leading biotech and technology companies in the industry.